Clinical trial · Interventional
Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Headache following a lumbar puncture (post-lumbar-puncture headache,PLPH)is a common and often debilitating syndrome, which was reported to occur in about 40% patients who received lumbar puncture. Now there lacks of effective approaches in the prophylaxis of PLPH, although some physicians consider bed rest for at least 6 hours to be a useful methods (Some recent meta-analysis found no benefit of bed rest for any hours in the prevention of PLPH). Studies have found that P substances and its receptor (Neurokinin-1 receptor, NK-1R)have played an important role in the pathogenesis of PLPH. Thus, we hypothesize that use of NK-1R inhibitor (aprepitant) 1 hour before lumbar puncture may decrease the incidence of PLPH and lower the severity of PLPH.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Aprepitant | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- treatment arm
- description
- this treatment arm will received aprepitant 1 hour before lumbar puncture and intrathecal treatment.
- interventionNames
- Drug: Aprepitant
- type
- NO_INTERVENTION
- label
- control arm
- description
- this arm will received nothing 1 hour before lumbar puncture
Primary outcomes (1)
- measure
- incidence of any grade post-lumbar-puncture headache
- timeFrame
- date from the day of lumbar puncture to 2 weeks after lumbar puncture
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 16 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed as acute leukemia, or lymphoma * Patients will received repeated lumbar puncture (at least 2 times, and at least 2 weeks apart) and intrathecal treatment * Without CNS involvement * Without headache for at least 1 week before the day of lumbar puncture * The platelet count was at least 30×10e9/L Exclusion Criteria: * With CNS involvement of disease * With headache before lumbar puncture * Needs lumbar puncture more than once a week
References
Publications (0)
Data not yet available